Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies

American Journal of Rhinology

Volumn 16, Issue 6, 2002, Pages 329-336

  Furukido, Kyosuke ^a   Takeno, Sachio ^a   Ueda, Tsutomu ^a   Hirakawa, Katsuhiro ^a   Yajin, Koji ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; RANTES; SUPLATAST TOSYLATE;

ABDOMINAL DISEASE; ADULT; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DROWSINESS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; MALE; PERENNIAL RHINITIS; PROTEIN SECRETION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 0036870106     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240201600609     Document Type: Article

References (20)

1. Baroody FM, and Naclerio RM. Antiallergic effects of H1-receptor antagonists. Allergy 55(suppl 64):17-27, 2000.
2. Matsuura N, Yanagihara Y, Mori H, et al. An immunopharmacological study of (±)[2-[4-(3-ethoxy-2-hydroxypropoxy) phenylcarcamoyl] ethyl] dimethylsulfonium p-toluensulfonate (IPD-1151T). Jpn Pharmacol Ther 22:1369-1383, 1994.
3. Oda N, Minoguchi K, Yokoe T, et al. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell line. Life Sci 65:763-770, 1999.
4. Matsuura N, Mori H, Nagai H, et al. Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice. Nippon Yakurigaku Zasshi 100:485-493, 1992.
5. Kobayashi Y, Nagata M, Yamamoto H, et al. Inhibitory effect of suplatast tosilate on eosinophil migration. Arerugi 49:600-603, 2000.
6. Sano Y, Miyamoto T, and Makino S. Anti-inflammatory effect of suplatast tosilate on mild asthma. Chest 112:862-863, 1997.
7. Suto H, Mitsuishi K, Hira K, et al. The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis. Arerugi 49:1163-1172, 2000.
8. Washio Y, Ohashi Y, Tanaka A, et al. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial AR. Acta Otolaryngol Suppl 538: 126-132, 1998.
9. Annunziato F, Cosmi L, Manetti R, et al. Reversal of human allergen-specific CRTH2+ T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J Allergy Clin Immunol 108:815-821, 2002.
10. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 105:399-408, 2000.
11. de Vries JE, Carballido JM, and Aversa G. Receptors and cytokines involved in allergic Th2 cell responses. J Allergy Clin Immunol 103:492-496, 1999.
12. Okuda M. A survey of rhinitis in Japan and an evaluation of the treatment with sodium cromoglycate. Rhinology 20:63-72, 1982.
13. Kawamoto. H, Takeno S, and Yajin K. Increased expression of inducible nitric oxide synthase in nasal epithelial cells in patients with AR. Laryngoscope 109:2015-2020, 1999.
14. Baba S, Takasaka T, Baba K, et al. Clinical evaluation of IPD-1151T on AR-double blind comparative study with Tranilast [in Japanese]. Enshou 12:379-397, 1992.
15. Umetsu DT, and DeKruyff RH. Th1 and Th2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 100:1-6, 1997.
16. Vilcek J, and Junming Le. Immunology of cytokines: an introduction. In The Cytokine Handbook, 2nd ed. Thomson A (Ed). New York: Academic Press, 1-21, 1994.
17. Li L, Crowley M, Nguyen A, et al. Ability of a nondepleting anti-CD4 antibody to inhibit Th2 responses and allergic lung inflammation is independent of coreceptor function. J Immunol 163:6557-6566, 1999.
18. Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633, 1996.
19. Taniguchi H, Togawa M, Ohwada K, et al. Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs. Eur J Pharmacol 318:447-454, 1996.
20. Terada N, Maesako K, Hamano N, et al. RANTES production in nasal epithelial cells and endothelial cells. J Allergy Clin Immunol 98: 230-237, 1996.